Best trading strategy for XRP
On XRP, the strongest tested strategy is Confluence — Sharpe 1.54 net of fees, slippage and funding over 2024-08-15 → 2026-07-05, across 264 trades. Of the 12 single-asset strategies we backtested on XRP, 5 cleared the Sharpe 1.0 bar. Every number below is a real Hyperliquid backtest, not a claim.
The XRP strategy leaderboard
Every strategy ranked by net Sharpe. Rows that clear the Sharpe 1.0 bar are highlighted; failed and wiped-out runs stay visible — click any strategy for its full multi-asset backtest.
| Strategy | Net Sharpe | Return | Max DD | Trades | Confidence |
|---|---|---|---|---|---|
| Confluenceclears bar | 1.54 | +24.5% | −5.4% | 264 | ok |
| Supertrend Bollingerclears bar | 1.35 | +34.2% | −8.8% | 15 | low |
| ADX Trendclears bar | 1.20 | +23.3% | −10.1% | 56 | moderate |
| MA Crossoverclears bar | 1.11 | +29.7% | −9.8% | 109 | ok |
| MACD Crossoverclears bar | 1.00 | +18.0% | −12.7% | 480 | ok |
| AI Trading Bot | 0.83 | +20.1% | −13.2% | 108 | ok |
| Stochastic | 0.74 | +7.3% | −3.7% | 48 | moderate |
| Supertrend | 0.73 | +17.0% | −15.5% | 24 | low |
| Ichimoku Cloud | 0.58 | +35.1% | −74.5% | 23 | low |
| RSI | 0.54 | +4.2% | −3.7% | 16 | low |
| Breakout | 0.33 | -3.8% | −80.7% | 90 | moderate |
| Mean Reversion | 0.28 | +2.2% | −4.5% | 37 | moderate |
2024-08-15 → 2026-07-05 · net of fees, slippage, and funding · one engine, one window, one cost model for every strategy — no cherry-picking.
The return column reflects each strategy’s own position sizing (some hold only a small slice of one coin), so Sharpe — which isn’t affected by leverage — is the fair way to rank them. 3 strategies that rank coins against each other (like funding carry and momentum ranking) can't run on a single asset, so they're left out.
Confluence cleared the bar on XRP (Sharpe 1.54). Start it on your own Hyperliquid account, or fork it and change the settings first.
At $1,000, Confluence's worst historical dip on XRP was about $54. Free account, your own keys — Keel only places the trades.
What this is: a single-asset backtest of 12 systematic strategies on XRP, on real Hyperliquid data, net of fees, slippage and funding. A high Sharpe on a low trade count is a small sample, not a promise. Where nothing clears the bar, we say so. Past performance does not predict future results, and this is not investment advice.